Asahi Kasei To Collaborate With Vernalis For Automimmune Drugs
This article was originally published in PharmAsia News
Executive Summary
Asahi Kasei Pharma, a Japan-based healthcare-development company, has signed a research-collaboration pact with U.K- based Vernalis for developing a drug targeted at autoimmune diseases such as rheumatoid arthritis.